RecallDepth
Class III Terminated

Oxcarbazepine Tablets, 150 mg, packaged in a) 10 x 10 count Unit-Dose Tablets in blisters packaged in a carton (NDC 0054-0097-20) and b) 100-count bottle (NDC 0054-0097-25), Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216

Company
Boehringer Ingelheim Roxane Inc
Recall Initiated
March 18, 2013
Posted
December 18, 2013
Recall Number
D-343-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
8,550 cartons and bottles
Firm Location
Columbus, OH, United States

Reason for Recall

SubPotent Drug: The firm discovered out of specification results for assay and the extended investigation revealed the potential for lower weight tablets.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: a) 259666A, Exp. MAR 2014; b) 259666B, Exp. MAR 2014

More recalls by Boehringer Ingelheim Roxane Inc

View all recalls by this company →

Other recent Class III Drug recalls